ANAVEX LIFE SCIENCES CORP. Quarterly Debt-to-equity in % from Q1 2012 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Anavex Life Sciences Corp. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q4 2024.
  • Anavex Life Sciences Corp. Debt-to-equity for the quarter ending December 31, 2024 was 10 %, a 14% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 10 +1.23 +14% Dec 31, 2024
Q3 2024 9.43 +0.49 +5.48% Sep 30, 2024
Q2 2024 8.55 +0.02 +0.24% Jun 30, 2024
Q1 2024 8.16 Mar 31, 2024
Q4 2023 8.8 Dec 31, 2023
Q3 2023 8.94 Sep 30, 2023
Q2 2023 8.52 Jun 30, 2023
Q3 2016 29.4 -20.8 -41.4% Sep 30, 2016
Q2 2016 23.5 -117 -83.3% Jun 30, 2016
Q1 2016 22.3 -113 -83.6% Mar 31, 2016
Q4 2015 23.2 -83.1 -78.2% Dec 31, 2015
Q3 2015 50.1 -38.9 -43.7% Sep 30, 2015
Q2 2015 141 +68.3 +94.3% Jun 30, 2015
Q1 2015 135 -1.27K -90.3% Mar 31, 2015
Q4 2014 106 +211 Dec 31, 2014
Q3 2014 89.1 +193 Sep 30, 2014
Q2 2014 72.5 +173 Jun 30, 2014
Q1 2014 1.4K +1.5K Mar 31, 2014
Q4 2013 -105 -2.23 -2.17% Dec 31, 2013
Q3 2013 -104 -0.77 -0.75% Sep 30, 2013
Q2 2013 -101 +4.99 +4.72% Jun 30, 2013
Q1 2013 -101 +22.4 +18.1% Mar 31, 2013
Q4 2012 -103 Dec 31, 2012
Q3 2012 -103 Sep 30, 2012
Q2 2012 -106 Jun 30, 2012
Q1 2012 -123 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.